Lymphocyte survival - The struggle against death

Annual Review of Cell and Developmental Biology

Volumn 15, Issue , 1999, Pages 113-140

  Arch, R H ^a   Thompson, C B ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Apoptosis; Co stimulation; Lymphocytes; Signal transduction; TNFR superfamily

Indexed keywords

ADAPTOR PROTEIN; CASPASE; CELL SURFACE RECEPTOR; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; PROTEIN BCL 2; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; APOPTOSIS; CELL DEATH; ENZYME ACTIVITY; LYMPHOCYTE ACTIVATION; LYMPHOID CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL DEATH; CELL MEMBRANE; CELL NUCLEUS; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MITOCHONDRIA; RECEPTORS, CELL SURFACE; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION;

ANIMALIA; VERTEBRATA;

EID: 0033280694     PISSN: 10810706     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.cellbio.15.1.113     Document Type: Review

References (247)

1. The Bcl-2 protein family: Arbiters of cell survival
2. CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/tumor necrosis factor receptor-interacting protein RIP
3. Differential signaling by lymphocyte antigen receptors
4. Molecular and biological characterization of human 4-1BB and its ligand
5. Human ICE/CED-3 protease nomenclature
6. A homologue of the TNF receptor and its lig- and enhance T-cell growth and dendritic-cell function
7. Inhibition of Bax channel-forming activity by Bcl-2
8. Tumor necrosis factor receptor-associated factors (TRAFs) - A family of adapter proteins that regulates life and death
9. 4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor κB
10. Fas-induced activation of the cell death-related protease CPP32 is inhibited by Bcl-2 and by ICE family protease inhibitors
11. Activate NFκB or die?
12. Cloning the chromosomal breakpoint of t(14;18) human lymphomas: Clustering around JH on chromosome 14 and near a transcriptional unit on 18
13. The NF-κB and IκB proteins: New discoveries and insights
14. Crystal structure of the soluble human 55 kd TNF receptorhuman TNFβ complex: Implications for TNF receptor activation
15. Cloning, expression and cross-linking analysis of the murine p55 tumor necrosis factor receptor
16. TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95)
17. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
18. L can inhibit apoptosis in cells that have undergone Fas-induced protease activation
19. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death
20. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain
21. Bcl-2 and adenovirus E1B 19 kDA protein prevent E1A-induced processing of CPP32 and cleavage of poly(ADP-ribose) polymerase
22. Cloning of mouse Ox40: A T cell activation marker that may mediate T-B cell interactions
23. The T cell activation antigen CD27 is a member of the nerve growth factor/tumor necrosis factor receptor gene family
24. TRAF6 is a signal transducer for interleukin-1
25. The regulation of anoikis: MEKK-1 activation requires cleavage by caspases
26. DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis
27. Specific cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death
28. Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein Daxx
29. L-regulated apoptosis in T cell development
30. BCL-2 family: Regulators of cell death
31. L and Bcl-2 repress a common pathway of cell death
32. Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-κB pathway
33. Conversion of Bcl-2 to a Bax-like death effector by caspases
34. TANK, a co-inducer with TRAF2 of TNF- and CD 40L-mediated NF-κB activation
35. Involvement of CRAF1, a relative of TRAF, in CD40 signaling
36. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis
37. Role of CED-4 in the activation of CED-3
38. The celldeath machine
39. Interaction of CED-4 with CED3 andCED-9: A molecular framework for cell death
40. FADD, a novel death domaincontaining protein, interacts with the death domain of Fas and initiates apoptosis
41. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95
42. L function upstream of the CED-3-like apoptotic proteases
43. Solution structure of the RAIDD CARD and model for CARD/CARD interaction in caspase-2 and caspase-9 recruitment
44. L through caspase interaction
45. A lymphotoxinβ-specific receptor
46. Proteases to die for
47. Caspase-3-mediated cleavage of protein kinase C θ in induction of apoptosis
48. Epstein-Barr virus and Hodgkin's disease: Transcriptional analysis of virus latency in the malignant cells
49. - T lymphocytes by 4-1BB ligand
50. The novel receptor TRAIL-R4 induces NFκB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain
51. Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family
52. CD30-mediated signaling promotes the development of human T helper type 2-like T cells
53. Signaling by dual specificity kinases
54. RAIDD is a new 'death' adaptor molecule
55. Induction of nuclear factor κB by the CD30 receptor is mediated by TRAF1 and TRAF2
56. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease
57. Proteolytic activation of protein kinase C δ by an ICE-like protease in apoptotic cells
58. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD
59. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome
60. Mouse lymphotoxin-β receptor. Molecular genetics, ligand binding, and expression
61. Proteolytic activation of protein kinase C δ by an ICE/CED 3-like protease induces characteristics of apoptosis
62. Expression of the costimulatory receptor CD30 is regulated by both CD28 and cytokines
63. A link between cell cycle and cell death: Bax and Bcl-2 modulate Cdk2 activation during thymocyte apoptosis
64. CASH, a novel caspase homologue with death effector domains
65. Molecular cloning and expression of the type 1 and type 2 murine receptors for tumor necrosis factor
66. Apoptosis induced in Jurkat cells by several agents is preceded by intracellular acidification
67. Cloning and expression of murine CD27: Comparison with 4-1BB, another lymphocyte-specific member of the nerve growth factor receptor family
68. L prevents this release but not tumor necrosis factor-R1/Fas death
69. Tumor necrosis factor ligand superfamily: Involvement in the pathology of malignant lymphomas
70. L and initiates cell death
71. Complementary DNA cloning of a receptor for tumor necrosis factor and demonstration of a shed form of the receptor
72. Caenorhabditis elegans gene ced-9 protects cells from programmed cell death
73. Epstein-Barr virus in Hodgkin's disease
74. Molecular cloning and expression of human and rat tumor necrosis factor receptor chain (p60) and its soluble derivative, tumor necrosis factor-binding protein
75. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
76. Bcl-2 functions in an antioxidant pathway to prevent apoptosis
77. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex
78. TRADD-TRAF2 and TRADD-FADD inter-actions define two distinct TNF receptor 1 signal transduction pathways
79. ATAR, a novel tumor necrosis factor receptor family member, signals through TRAF2 and TRAF5
80. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation
81. A novel RING finger protein interacts with the cytoplasmic domain of CD40
82. I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1- and CD-95-induced apoptosis
83. NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain
84. A thousand and one protein kinases
85. Protein kinases and phosphatases: The yin and yang of protein phosphorylation and signaling
86. Potential role of 4-1BB in T cell activation. Comparison with the costimulatory molecule CD28
87. Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death
88. Potential role of 4-1BB in T cell activation. Comparison with the costimulatory molecule CD28
89. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways
90. CLARP, a death effector domaincontaining protein interacts with caspase-8 and regulates apoptosis
91. Inhibition of death receptor signals by cellular FLIP
92. Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region
93. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
94. Prevention of constitutive TNF receptor 1 signaling by silencer of death domains
95. The B7 and CD28 receptor families
96. Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade
97. Hodgkin and Reed-Steinberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells
98. AP-1 function and regulation
99. The death domain kinase RIP mediates the TNF-induced NF-κB signal
100. Cyclic re-entry of germinal center B cells and the efficiency of affinity maturation
101. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
102. A death-domain-containing receptor that mediates apoptosis
103. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis
104. Bcl-2 and Bax function independently to regulate cell death
105. + naive T cell costimulation
106. A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor
107. Caspase-3-generated fragment of gelsolin: Effector of morphological change in apoptosis
108. Immunopathology of interleukin (IL) 2-deficient mice: Thymus dependence and suppression by thymus-dependent cells with an intact IL-2 gene
109. Immune responses in interleukin-2-deficient mice
110. The origin of Hodgkin and Reed/Sternberg cells in Hodgkin's disease
111. Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development
112. A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation
113. cDNA sequences of two inducible T-cell genes
114. The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor κB
115. The human OX40 homolog: cDNA structure, expression and chromosomal assignment of the ACT35 antigen
116. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE
117. Studies of the lamin proteinase reveal multiple parallel biochemical pathways during apoptotic execution
118. Activation of hPAK65 by caspase cleavage induces some of the morphological and biochemical changes of apoptosis
119. TRAF-interacting protein (TRIP): A novel component of the tumor necrosis factor receptor (TNFR)- and CD30-TRAF signaling complexes that inhibits TRAF2-mediated NF-κB activation
120. CD28/B7 system of T cell costimulation
121. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific
122. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis
123. Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients
124. pr-bcl-2 transgenic mice
125. Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation
126. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c
127. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis
128. Germinal center development
129. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death
130. Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor
131. Purification and partial amino acid sequence analysis of two distinct tumor necrosis factor receptors from HL60 cells
132. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors
133. Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL
134. MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1
135. Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes-a molecule related to nerve growth factor receptor
136. Mitochondrial permeability transition is a central coordinating event of apoptosis
137. Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-κB
138. Identification of a ligand for the death-domain-containing receptor Apo3
139. A novel receptor for Apo2L/TRAIL contains a truncated death domain
140. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl
141. 53, and Bax but not the survival gene bcl-2
142. Regulation of cell division cycle progression by bcl-2 expression: A potential mechanism for inhibition of programmed cell death
143. bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation
144. Progression from lymphoid hyperplasia to highgrade malignant lymphoma in mice transgenic for the t(14;18)
145. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC)
146. Elevated soluble Fas (sFas) levels in nonhematopoietic human malignancy
147. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family
148. Cloning and characterization of the gene encoding human osteoprotegerin/osteoclastogenesis-inhibitory factor
149. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family
150. L, an inhibitor of programmed cell death
151. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex
152. Apoptosis: Telling cells their time is up
153. Apoptosis by death factor
154. The Fas death factor
155. Structures of the extracellular domain of the type I tumor necrosis factor receptor
156. TRAF5, an activator of NF-κB and putative signal transducer for the lymphotoxin-β receptor
157. A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes
158. A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis
159. Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor
160. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen
161. The A20 cDNA induced by tumor necrosis factor a encodes a novel type of zinc finger protein
162. The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity
163. The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry
164. Identification and functional characterization of DR6, a novel death domain-containing TNF receptor
165. An antagonist decoy receptor and a death domain-containing receptor for TRAIL
166. TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling
167. The receptor for the cytotoxic ligand TRAIL
168. Hypercross-linking surface IgM or IgD receptors on mature B cells induces apoptosis that is reversed by costimulation with IL-4 and anti-CD40
169. Signaling through scaffold, anchoring, and adaptor proteins
170. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer
171. Gene transfer and molecular cloning of the rat nerve growth factor receptor
172. Social controls on cell survival and cell death
173. Lamin proteolysis facilitates nuclear events during apoptosis
174. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis
175. Presence of a new conserved domain in CART1, a novel member of the tumor necrosis factor receptor-associated protein family, which is expressed in breast carcinoma
176. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity
177. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins
178. TRAF2-mediated activation of NFκB by TNF receptor 2 and CD40
179. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor
180. I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction
181. The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis
182. Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2
183. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene
184. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis
185. FAP-1: A protein tyrosine phosphatase that associates with Fas
186. A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40
187. Molecular cloning and expression of a receptor for human tumor necrosis factor
188. HIV-induced T-lymphocyte depletion
189. Development and function of T cells in mice rendered inteleukin-2 deficient by gene targeting
190. A receptor induced by lymphocyte activation (ILA): A new member of the human nerve-growth-factor/tumor-necrosis-factor receptor family
191. TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL
192. LARD: A new lymphoidspecific death domain containing receptor regulated by alternative pre-mRNA splicing
193. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes
194. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors
195. Bcl-2 expression prevents activation of the ICE protease cascade
196. Casper is a FADD- and caspase-related inducer of apoptosis
197. + T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses
198. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density
199. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins
200. Tumor necrosis factor (TNF)-mediated kinase cascades: Bifurcation of nuclear factor-κB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2
201. The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-κB activation
202. DNA-dependent protein kinase catalytic subunit: A target for an ICE-like protease in apoptosis
203. Interaction between the C. elegans cell-death regulators CED-9 and CED-4
204. FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/TNFRl-induced apoptosis
205. A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas
206. RIP: A novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death
207. Mechanisms and genes of cellular suicide
208. Bcl-2 expression promotes B- but not T-lymphoid development in scid mice
209. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship
210. Eμ-bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulinsecreting cells but not T cells
211. Molecular characterization of mitochondrial apoptosis-inducing factor
212. The central executioner of apoptosis: Multiple connections between protease activation and mitochondria in Fas/APO-1/CD95- and ceramide-induced apoptosis
213. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease
214. Mitochondria as regulators of apoptosis: Doubt no more
215. Deregulated T cell activation and autoimmunity in mice lacking inteleukin-2 receptor β
216. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand
217. Anatomy of TRAF2. Distinct domains for nuclear factor-κB activation and association with tumor necrosis factor signaling proteins
218. A novel domain within the 55 kd TNF receptor signals cell death
219. Two TNF receptors
220. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors
221. Apoptosis in the pathogenesis and treatment of disease
222. Caspases: Enemies within
223. L regulates the membrane potential and volume homeostasis of mitochondria
224. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
225. NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily
226. TRAIL-R2: A novel apoptosis-mediating receptor for TRAIL
227. Crystal structure of the cysteine protease interleukin-1β-converting enzyme: A (p20/p10)2 homodimer
228. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
229. Cleavage of focal adhesion kinase by caspases during apoptosis
230. Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment
231. Structure and mechanism of interleukin-1β converting enzyme
232. Interaction and regulation of subcellular localization of CED-4 by CED-9
233. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene
234. Chromatin cleavage in apoptosis: Association with condensed chromatin morphology and dependence on macromolecular synthesis
235. BAX-induced cell death may not require interleukin 1β-converting enzyme-like proteases
236. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked
237. Daxx, a novel Fas-binding protein that activates JNK and apoptosis
238. FADD: Essential for embryo development and signaling from some, but not all, inducers of apoptosis
239. Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice
240. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme
241. OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40
242. Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosis
243. Mitochondrial control of nuclear apoptosis
244. L
245. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mortl
246. p53-dependent impairment of T-cell proliferation in FADD dominant-negative transgenic mice
247. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3